Skip to main content
. 2022 Oct 21;10(1):432–441. doi: 10.1002/ehf2.14204

Figure 3.

Figure 3

ROC analysis of individual biomarkers at baseline and 6 months to predict left ventricular ejection fraction (LVEF) at 12 months. (A) hsTnT, high‐sensitivity troponin T. (B) ST2, suppression of tumorigenicity 2. (C) NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. (D) CCN1, cellular communication network factor 1.